Targeting CD38 for acute leukemia

Acute leukemia (AL) is a hematological malignancy, and the prognosis of most AL patients hasn’t improved significantly, particularly for relapsed or refractory (R/R) AL. Therefore, new treatments for R/R adult acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are urgently necessary...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Xushu, Ma, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597453/
https://www.ncbi.nlm.nih.gov/pubmed/36313735
http://dx.doi.org/10.3389/fonc.2022.1007783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597453/
https://www.ncbi.nlm.nih.gov/pubmed/36313735
http://dx.doi.org/10.3389/fonc.2022.1007783

Ejemplares similares